EP Patent

EP2985026A1 — Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same

Assigned to Besins Healthcare Luxembourg SARL · Expires 2016-02-17 · 10y expired

What this patent protects

A drug delivery system for oral administration of hydrophobic drugs with enhanced and extended absorption and improved pharmacokinetics is provided. In one embodiment, formulations comprising testosterone and testosterone esters are disclosed. Method of treating a hormone deficie…

USPTO Abstract

A drug delivery system for oral administration of hydrophobic drugs with enhanced and extended absorption and improved pharmacokinetics is provided. In one embodiment, formulations comprising testosterone and testosterone esters are disclosed. Method of treating a hormone deficiency or effecting male contraception with the formulations are also provided.

Drugs covered by this patent

Patent Metadata

Patent number
EP2985026A1
Jurisdiction
EP
Classification
—
Expires
2016-02-17
Drug substance claim
No
Drug product claim
No
Assignee
Besins Healthcare Luxembourg SARL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.